Sign in
8-K

Current Report

Arbutus Biopharma Corp Filed Acc 0001171843-18-000976

Exit or restructuring costs · Regulation FD disclosure

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading f8k_020818.htm…